May 1, 2026 09:02 AM EDTUpdated 03:04 PM FDA+ Amgen files update to Tavneos label as FDA escalates push to withdraw Nicole DeFeudis Senior Reporter Amgen has taken steps to update its Tavneos label amid an ongoing battle with the FDA. The company filed a supplement … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
81 words · extracted 2mo agoread original ↗
comments(0)
5-min edit window · permanent after that